Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00865_DB01367_nanopub.RA78LOkf-O8b3o8aUdQd4uRCnkMCnU3pkpWZTak710y4o#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00865_DB01367 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00865_DB01367 label "DDI between Benzphetamine and Rasagiline - MAO Inhibitors may enhance the hypertensive effect of Amphetamines. Concomitant use of amphetamines and monoamine oxidase inhibitors (MAOI) should be avoided. If used concomitantly, careful monitoring of blood pressure must occur. It may take up to 2 weeks after the discontinuation of an MAOI for the effects to dissipate enough to afford safety to the administration of interacting agents. [drugbank_resource:DB00865_DB01367]" assertion.
- drugbank_resource:DB00865_DB01367 identifier "drugbank_resource:DB00865_DB01367" assertion.
- drugbank_resource:DB00865_DB01367 title "DDI between Benzphetamine and Rasagiline - MAO Inhibitors may enhance the hypertensive effect of Amphetamines. Concomitant use of amphetamines and monoamine oxidase inhibitors (MAOI) should be avoided. If used concomitantly, careful monitoring of blood pressure must occur. It may take up to 2 weeks after the discontinuation of an MAOI for the effects to dissipate enough to afford safety to the administration of interacting agents." assertion.
- drugbank:DB00865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00865_DB01367 assertion.
- drugbank:DB01367 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00865_DB01367 assertion.